REQUEST A DEMO
Total
USD $0.00
Search more companies

Windlas Biotech Ltd. (India)

Main Activities: Basic Chemical Manufacturing
Full name: Windlas Biotech Ltd. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Windlas Biotech Private Limited is engaged in the business of manufacturing nutraceutical, pharmaceutical and ayurvedic products. Their products include brands such as Pfizer, Sanofi, zydus Cadila, Intas, Cadila, Systopic, Emcure, and Eris. The company was incorporated in 2001 and is located in Dehradun, India.

Legal Address
40/1, Mohabewala Industrial Area,, ,
Dehradun; Uttarakhand; Postal Code: 248110

Contact Details: Purchase the Windlas Biotech Ltd. report to view the information.

Website: http://www.windlasbiotech.com

Basic Information
Total Employees:
Purchase the Windlas Biotech Ltd. report to view the information.
Outstanding Shares:
Purchase the Windlas Biotech Ltd. report to view the information.
Registered Capital:
Purchase the Windlas Biotech Ltd. report to view the information.
Financial Auditors:
Purchase the Windlas Biotech Ltd. report to view the information.
Incorporation Date:
February 19, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Co. Secretary & Compl. Officer
Ownership Details
Purchase this report to view the information.
62.51%
Purchase this report to view the information.
21.8%
Purchase this report to view the information.
7.57%
Purchase this report to view the information.
4.11%
Purchase this report to view the information.
2.01%
Company Performance
Financial values in the chart are available after Windlas Biotech Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
20.97%
Total operating revenue
20.97%
Operating profit (EBIT)
5.16%
EBITDA
21.82%
Net Profit (Loss) for the Period
11.77%
Total equity
0.48%
Operating Profit Margin (ROS)
-1.25%
Net Profit Margin
-0.63%
Return on Equity (ROE)
13.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?